Protalix Biotherapeutics, Inc. (PLX)
1.90
-0.01
(-0.52%)
USD |
NYAM |
May 19, 16:00
1.92
+0.02
(+1.05%)
After-Hours: 20:00
Protalix Biotherapeutics Shareholders Equity (Quarterly) : 67.23M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -221.22M |
| Lisata Therapeutics, Inc. | 10.93M |
| Curis, Inc. | 12.71M |
| LadRx Corp. | -2.135M |
| Plus Therapeutics, Inc. | 11.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 102.34M |
| Total Liabilities (Quarterly) | 35.11M |
| Debt to Equity Ratio | 0.1262 |
| Current Ratio | 3.153 |
| Net Debt Paydown Yield | -0.34% |